Skip to main content
Fig. 6 | Biology Direct

Fig. 6

From: An integrative in-silico analysis discloses a novel molecular subset of colorectal cancer possibly eligible for immune checkpoint immunotherapy

Fig. 6

Results of immune signatures analysis performed by ImSig. The boxplots (A and B) show the gene expression of T and NK signature genes (estimated relative abundance) across the HM, non-HM and HM-like groups. Statistical analysis of data was performed using analysis of variance (ANOVA) followed by multiple comparison Tukey’s test. **P < .01, *P < .05

Back to article page